HSP70-TLR4-mediated MDSC Recruitment as an Adaptive Resistance
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
Merck Sharp & Dohme
Start Date
February 13, 2019
End Date
September 1, 2024
Administered By
Medicine, Medical Oncology
Awarded By
Merck Sharp & Dohme
Start Date
February 13, 2019
End Date
September 1, 2024